New concepts for a lifelong challenge – tumor-associated VTE.

There has been a groundbreaking increase in knowledge in hemostaseology in recent years, both preclinically in basic research and clinically with the development of innovative treatment strategies. Using the patient as a benchmark means highlighting the latest developments in hemostaseology research in terms of their impact on current and future patient care. This year’s annual conference lived up to this claim.